Skip to content

Clinical trials

Phase 2 Rectal Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 2 Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20061
20092
20101
20112
20121
20151
20171
20181
20201
20221
20231
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Active, not recruiting2
Terminated2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital Tuebingen3
Sanofi2
AIO-Studien-gGmbH1
Amgen1
Charite University, Berlin, Germany1
Delcath Systems Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1
Gruppo Oncologico del Nord-Ovest1
Heidelberg University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms20
Colonic Neoplasms7
Colorectal Neoplasms6
Neoplasm Metastasis4
Hyperthermia2
Anus Neoplasms1
Carcinoma, Squamous Cell1
Esophageal Neoplasms1
Fever1
Neuroendocrine Tumors1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.